Comments

View 3 Images

Brits will be no stranger to weight loss jabs. Even if they have not partaken in the growing medical trend themselves, they probably know someone who has. ‌

Mounjaro , or Tirzepatide to give it its medical name, is one particular injectable that has drawn significant notice and media coverage. ‌

Initially developed for the management of type 2 diabetes , the medication has been licensed in the UK for obesity treatment since November 2024, earning acclaim for its effectiveness in facilitating substantial weight loss. ‌

However, pharmacists are now warning Mounjaro users to check medication leaflets following growing concern about gall bladder issues related to weight loss injections.

The weight loss injection experts at Chemist4U are urging users to che

See Full Page